Abiron Injection
Marketer
Acekinetics Healthcare Pvt Ltd
Salt Composition
Piroxicam (20mg)
Overview Abiron Injection
Anavil Injection provides analgesia for moderate to severe pain. Indicated for musculoskeletal pain and inflammation, it's administered parenterally when oral routes are infeasible. Administration should always be by a qualified healthcare professional; self-injection is strictly prohibited. Dosage and treatment length are individualized based on response and underlying condition, continuing until medically discontinued. Commonly reported adverse effects include injection site reactions (pain, erythema, edema), nausea, abdominal pain, dyspepsia, diarrhea, cephalgia, and vertigo. Persistent or worsening side effects warrant immediate medical attention; management strategies may be available. Prior to use, disclose any history of peptic ulcers, cardiovascular disease, hypertension, or hepatic/renal impairment. Complete disclosure of all concomitant medications is crucial due to potential interactions. Use during pregnancy or lactation is contraindicated; consultation with a physician is mandatory. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with blood component levels.
Uses of Abiron Injection
Analgesia
Major Benefits of Abiron Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Abiron Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Stomach pain
- Nausea
- Headache
- Dizziness
How to use Abiron Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Abiron Injection works:
Abiron Injection, a non-steroidal anti-inflammatory medication, inhibits the production of inflammatory mediators, thus alleviating pain and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of Abiron Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Abiron Injection during pregnancy poses a confirmed risk to the fetus. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Use of Abiron Injection while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Abiron Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should use Abiron Injection with careful monitoring. Dosage modification for Abiron Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should receive Abiron Injection with careful monitoring. Dosage modification of Abiron Injection may be necessary. Physician consultation is advised.
What if you forget to take Abiron Injection :
Omit a dose of Abiron Injection? Seek your physician's advice.
Facts to Know About Abiron Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Esters of enolic acids |
| Addictive | None. |
| Medication Category | Pain relievers |
FAQs on Abiron Injection
Abiron Injection and diclofenac are analgesics. Unlike diclofenac, which exhibits preferential inhibition of the COX-2 enzyme, piroxicam non-selectively inhibits cyclooxygenase (COX), an enzyme crucial in pain and inflammation generation. This preferential COX-2 inhibition by diclofenac is believed to reduce adverse effects relative to Abiron Injection.
Abiron Injection and naproxen are analgesic medications, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain sensation. Clinical trials indicate comparable efficacy between the two. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse effects than Abiron Injection.
Abiron Injection and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain sensation. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse effects relative to Abiron Injection.
Abiron Injection and ketoprofen are both analgesic medications, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate superior efficacy for topical ketoprofen gel relative to Abiron Injection. Furthermore, the gel demonstrated a high level of patient acceptance.
Abiron Injection targets COX enzymes, key players in inflammation and pain production, while Tramadol offers pain relief through a narcotic-like mechanism. Tramadol carries a risk of dependence.
Abiron Injection and nimesulide are analgesics. Abiron Injection broadly inhibits cyclooxygenase (COX), an enzyme crucial in inflammation and pain signaling, while nimesulide's action is targeted towards COX-2. This specific COX-2 inhibition in nimesulide is believed to reduce adverse effects relative to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet count. However, analgesics such as piroxicam may heighten the risk of bleeding. Therefore, avoid Abiron Injection or other pain relievers if you experience fever with joint pain. Seek medical advice before using Abiron Injection.
Abiron Injection and aspirin are distinct medications, despite both being classified as COX (cyclooxygenase) inhibitors. Both possess anti-inflammatory and analgesic properties.
Concurrent administration of Abiron Injection and dexamethasone is contraindicated due to their synergistic toxicity, significantly elevating the risk of gastrointestinal ulceration.
Concurrent use of methocarbamol and Abiron Injection is acceptable, as no significant adverse reactions have been reported. However, physician consultation is advised prior to initiating either treatment.
Confirmation: Concurrent use of paracetamol and Abiron Injection is acceptable, as no significant adverse reactions have been reported. Consult your physician prior to initiating either treatment.
Affirmative. Abiron Injection is classified as a non-steroidal anti-inflammatory medication.
Abiron Injection contains sulfur. This medication may trigger severe reactions in susceptible patients, including potentially life-threatening skin conditions such as Stevens-Johnson syndrome. Report any allergies to your physician.
Abiron Injection does not prevent blood clotting; it's an analgesic. Patients with hemorrhagic conditions should not use this medication.
Abiron Injection does not relax muscles. It's an analgesic that targets COX (cyclooxygenase), an enzyme mediating inflammation and pain.
Abiron Injection is non-narcotic. This analgesic reduces pain and inflammation by targeting the COX enzyme, a key player in inflammatory processes.
Abiron Injection does not treat high blood pressure. Concurrent administration of Abiron Injection reduces the efficacy of antihypertensive drugs. Disclose any antihypertensive medication use to your physician prior to commencing Abiron Injection therapy.
Concurrent administration of Abiron Injection and losartan is contraindicated. Abiron Injection reduces the efficacy of antihypertensive agents, such as losartan, potentially resulting in treatment failure. Disclose any current antihypertensive medication use to your physician prior to commencing Abiron Injection therapy.
Abiron Injection and lisinopril should not be used concurrently. Concomitant administration of piroxicam with lisinopril reduces the antihypertensive drug's efficacy, potentially resulting in treatment failure. Patients using antihypertensive medications should disclose this to their physician prior to commencing Abiron Injection therapy.
Confirmed. Abiron Injection is compatible with calcium channel blockers. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) diminish the efficacy of most antihypertensive medications, with calcium channel blockers representing an exception (White, 2007).
Tizanidine and Abiron Injection are compatible for concurrent administration. Piroxicam's analgesic properties complement tizanidine's action as a skeletal muscle relaxant, making the combination suitable for conditions such as back pain.
Affirmative. The concomitant administration of Abiron Injection and beta-cyclodextrin is feasible. Studies indicate this combination accelerates piroxicam's therapeutic effect and mitigates gastrointestinal adverse reactions.
Indeed, viable alternatives to Abiron Injection exist. Analgesic selection depends on the specific illness. It's crucial to seek medical advice prior to commencing piroxicam therapy or switching medications.
Piroxicam should not be used by individuals with allergies to the drug, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores (stomatitis), systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, during late pregnancy, heart conditions, liver dysfunction, or kidney impairment.
Abiron Injection does not alleviate allergic reactions; it is an analgesic.
Abiron Injection provides extended pain relief with a single daily dose. However, individual responses vary, and the analgesic effects of piroxicam generally improve with continued use over several weeks.
Abiron Injection does not produce euphoric effects. This medication is a non-opioid analgesic.
Abiron Injection lacks regulatory approval for managing dysmenorrhea. Clinical trials indicate that piroxicam offers substantial relief from menstrual pain.
Abiron Injection lacks regulatory approval for migraine treatment. Clinical trials demonstrate Abiron Injection's efficacy in substantially reducing migraine pain in patients without aura.
Confirmation. This medication may alleviate back pain. A physician's assessment to determine the underlying cause of your back pain is crucial before commencing treatment. Avoid self-administering Abiron Injection; back pain etiologies vary widely among individuals.
Indeed, Abiron Injection is an approved treatment option for acute gout. Clinical trials have demonstrated its significant efficacy in managing acute gout episodes.
Blood donation is permissible while using Abiron Injection; however, please disclose your Abiron Injection use to your physician prior to donation.
In diabetic patients, Abiron Injection should only be administered under strict medical supervision. Prolonged use of this medication carries a significant risk of kidney failure. Since diabetes is itself a contributing factor to kidney disease, the concurrent use of piroxicam (the active ingredient in Abiron Injection) substantially elevates this risk.
Abiron Injection is contraindicated in individuals with impaired kidney function. Prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been associated with kidney damage, including papillary necrosis.
Skin reactions, including potentially life-threatening conditions like exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, are known side effects of Abiron Injection. These severe reactions can develop unexpectedly. Any mild rash warrants immediate medical attention and cessation of the injection.
Abiron Injection is contraindicated during pregnancy. Its use can result in premature closure of the ductus arteriosus, potentially causing fetal heart failure and death.
Abiron Injection is not suitable for patients with active peptic ulcers. This medication is associated with the development of gastric ulcers and hemorrhage.
Individuals with asthma may exhibit heightened sensitivity to non-steroidal anti-inflammatory medications, including aspirin, potentially triggering severe asthma episodes. Physician consultation is advised prior to commencing treatment with such drugs.
Indeed, Abiron Injection may induce temporary infertility. Similarly, piroxicam's mechanism of action can potentially postpone or hinder ovarian follicle rupture, a phenomenon linked to reversible infertility in certain women. Physician consultation prior to commencing treatment is advisable.
Abiron Injection is contraindicated for concurrent administration with diuretics. In certain individuals, Abiron Injection diminishes the sodium-excreting action of furosemide and thiazide diuretics. This interaction is believed to result from the suppression of renal prostaglandin production.
Abiron Injection must not be administered concurrently with lithium. Its use results in increased lithium plasma concentrations and decreased renal lithium excretion. This effect stems from the nonsteroidal anti-inflammatory drug's (NSAID) inhibition of renal prostaglandin production. Physician consultation is mandatory prior to initiating Abiron Injection therapy.
Concurrent administration of Abiron Injection and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients using either medication should disclose this to their physician. Should co-administration be necessary, rigorous monitoring of the treatment is essential.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional contributing factors to this increased risk.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics, either immediately preceding or following cardiac bypass surgery.
Stomach upset is common, though severe gastrointestinal adverse reactions, including ulcers and hemorrhage, are infrequent. Serious skin reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis may occur, as can liver failure and kidney damage.
3,018 People bought this recently
Abiron Injection
20
MRP 24
16% off